Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022
Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022
Psychedelics Algernon partners with Yale University for phase II DMT study Algernon will provide cGMP DMT for the study in exchange for part-ownership of IP generated Rowan DunneOctober 24, 2022
Psychedelics Small Pharma acquires U.S. patent for its DMT compounds The company has enhanced its IP portfolio with a patent that will be valid until 2041 Rowan DunneOctober 21, 2022
International Psychedelic drugs market awaits nearly 100% revenue expansion by 2026 end: Fairfield The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period Rowan DunneOctober 20, 2022
International European Psychiatric Association aligns with PAREA: a multi-organization psychedelic partnership The new member organization consists of over 78,000 psychiatrists Rowan DunneOctober 17, 2022
News ASKP3 Patient Portal to offer accurate fact-based info on ketamine Platform is intended to educate patients and medical providers on benefits of ketamine for treating pain and mood disorders Rowan DunneOctober 14, 2022
Canada Alberta pioneers psychedelic therapy regulations in Canada New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients Rowan DunneOctober 6, 2022
Psychedelics Numinus develops psilocybin-infused tea bag for clinical studies The company plans to use mushroom tea to treat patients pending regulatory approvals Rowan DunneOctober 5, 2022
Psychedelics Choose Ketamine now offering at-home treatments in several states Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost Rowan DunneOctober 4, 2022